|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of eFFECTOR Therapeutics (NASDAQ: EFTR) through any online brokerage.
There are no as such competitors for eFFECTOR Therapeutics.
The latest price target for eFFECTOR Therapeutics (NASDAQ: EFTR) was reported by Credit Suisse on October 12, 2021. The analyst firm set a price target for 20.00 expecting EFTR to rise to within 12 months (a possible 88.50% upside). 5 analyst firms have reported ratings in the last year.
The stock price for eFFECTOR Therapeutics (NASDAQ: EFTR) is $10.61 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for eFFECTOR Therapeutics.
eFFECTOR Therapeutics’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for eFFECTOR Therapeutics.
eFFECTOR Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.